Leerink Partnrs Has Positive View of NeoGenomics Q3 Earnings
NeoGenomics, Inc. (NASDAQ:NEO – Free Report) – Equities research analysts at Leerink Partnrs lifted their Q3 2025 earnings per share (EPS) estimates for NeoGenomics in a research note issued on Tuesday, February 18th. Leerink Partnrs analyst P. Souda now anticipates that the medical research company will post earnings of $0.00 per share for the quarter, […]
NeoGenomics, Inc. (NASDAQ:NEO – Free Report) – Equities research analysts at Leerink Partnrs lifted their Q3 2025 earnings per share (EPS) estimates for NeoGenomics in a research note issued on Tuesday, February 18th. Leerink Partnrs analyst P. Souda now anticipates that the medical research company will post earnings of $0.00 per share for the quarter, […]
